These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
877 related articles for article (PubMed ID: 22674182)
61. Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer. Jiang X; Du L; Duan W; Wang R; Yan K; Wang L; Li J; Zheng G; Zhang X; Yang Y; Wang C Oncotarget; 2016 Jun; 7(24):36733-36742. PubMed ID: 27167342 [TBL] [Abstract][Full Text] [Related]
62. Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p. Zhu Y; Li T; Chen G; Yan G; Zhang X; Wan Y; Li Q; Zhu B; Zhuo W Lung Cancer; 2017 Dec; 114():6-11. PubMed ID: 29173767 [TBL] [Abstract][Full Text] [Related]
63. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma. Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588 [TBL] [Abstract][Full Text] [Related]
64. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917 [TBL] [Abstract][Full Text] [Related]
65. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma. Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019 [TBL] [Abstract][Full Text] [Related]
66. Identification of serum microRNAs as diagnostic and prognostic biomarkers for acute pancreatitis. Liu P; Xia L; Zhang WL; Ke HJ; Su T; Deng LB; Chen YX; Lv NH Pancreatology; 2014; 14(3):159-66. PubMed ID: 24854610 [TBL] [Abstract][Full Text] [Related]
67. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer. Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458 [TBL] [Abstract][Full Text] [Related]
68. Circulating microRNA expression profile: a novel potential predictor for chronic nervous lesions. Xu Y; Zhang X; Pu S; Wu J; Lv Y; Du D Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):942-9. PubMed ID: 25274330 [TBL] [Abstract][Full Text] [Related]
69. A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma. Zhi F; Shao N; Li B; Xue L; Deng D; Xu Y; Lan Q; Peng Y; Yang Y Sci Rep; 2016 Aug; 6():32067. PubMed ID: 27558167 [TBL] [Abstract][Full Text] [Related]
70. Analysis of expression of microRNAs and genes involved in the control of key signaling mechanisms that support or inhibit development of brain tumors of different grades. Koshkin PA; Chistiakov DA; Nikitin AG; Konovalov AN; Potapov AA; Usachev DY; Pitskhelauri DI; Kobyakov GL; Shishkina LV; Chekhonin VP Clin Chim Acta; 2014 Mar; 430():55-62. PubMed ID: 24412320 [TBL] [Abstract][Full Text] [Related]
71. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection. Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176 [TBL] [Abstract][Full Text] [Related]
72. MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft Vasculopathy. Neumann A; Napp LC; Kleeberger JA; Benecke N; Pfanne A; Haverich A; Thum T; Bara C Transplantation; 2017 Jan; 101(1):e26-e33. PubMed ID: 27653298 [TBL] [Abstract][Full Text] [Related]
73. Circulating microRNAs: potential biomarkers for common malignancies. Khoury S; Tran N Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901 [TBL] [Abstract][Full Text] [Related]
74. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection. Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774 [TBL] [Abstract][Full Text] [Related]
75. MiR-221 as a pre- and postoperative plasma biomarker for larynx cancer patients. Yilmaz SS; Guzel E; Karatas OF; Yilmaz M; Creighton CJ; Ozen M Laryngoscope; 2015 Dec; 125(12):E377-81. PubMed ID: 25945817 [TBL] [Abstract][Full Text] [Related]
76. Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus. Tan Y; Lin B; Ye Y; Wen D; Chen L; Zhou X Oncol Rep; 2015 Jun; 33(6):2863-70. PubMed ID: 25962820 [TBL] [Abstract][Full Text] [Related]
77. A Five-miRNA Panel Identified From a Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients. Wang C; Ding M; Xia M; Chen S; Van Le A; Soto-Gil R; Shen Y; Wang N; Wang J; Gu W; Wang X; Zhang Y; Zen K; Chen X; Zhang C; Zhang CY EBioMedicine; 2015 Oct; 2(10):1377-85. PubMed ID: 26629532 [TBL] [Abstract][Full Text] [Related]
78. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer. Zhang Y; Zhang D; Wang F; Xu D; Guo Y; Cui W Sci Rep; 2015 Dec; 5():17942. PubMed ID: 26656154 [TBL] [Abstract][Full Text] [Related]
79. Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer. Huang Z; Zhu D; Wu L; He M; Zhou X; Zhang L; Zhang H; Wang W; Zhu J; Cheng W; Chen Y; Fan Y; Qi L; Yin Y; Zhu W; Shu Y; Liu P Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):188-196. PubMed ID: 27756776 [TBL] [Abstract][Full Text] [Related]
80. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease. Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]